BIO-TECHNE Corp
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Minneapolis, MN
TECH chart
What traders are saying about $TECH
Latest postsBIO-TECHNE Corp news
- Qualcomm vs. Western Digital: Which Tech Stock Is a Better Buy for 2027?
The Motley Fool ·
- Humacyte, Inc. (HUMA) Reports Q3 Loss, Tops Revenue Estimates
Yahoo Finance ·
- China Chipmakers to Debut in HK in Test of Tech Stock Demand
Bloomberg.com ·
- Warren Buffett's Successor, Greg Abel, Just Added Another Tech Stock to Berkshire's Portfolio. Here's What He Sees.
Yahoo Finance ·
- SoftBank Group shares surge 14% as Asian tech stocks track Wall Street rebound
CNBC ·
- Astera Labs rallies 14% on tech stock surge (ALAB:NASDAQ)
Seeking Alpha ·
- UBS: Tech Stock Selloff Is AI Position Reshuffling, Not the End of AI Investment — Recommends Trimming Exposure on Rebound
BigGo Finance ·
- Bitcoin holds near $75,000 after tech stock rout, altcoins suffer steeper losses
Fortune ·
- Alphabet Makes $548 Million In Major Tech Stock, Keeps Massive S
GuruFocus ·
- Gold Gains as NVDA 'Spy' Scandal Extends Nasdaq Tech Stock Sell-Off
BullionVault ·
- TECH Q1 Earnings & Revenues Beat, Merck KGaA Merger Deal Advances
Yahoo Finance ·
- Roivant Sciences Ltd. (ROIV) Reports Q2 Loss, Tops Revenue Estimates
Yahoo Finance ·
BIO-TECHNE Corp key financials
| USD | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $1.22B | $1.22B | $1.16B | $1.14B |
| Net income | – | $73.4M | $168.1M | $285.3M |
| Diluted EPS | $1.16 | $0.46 | $1.05 | $1.76 |
| Total assets (year end) | – | $2.52B | $2.67B | $2.73B |
| Cash and equivalents (year end) | – | $172.9M | $177.5M | $130.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About BIO-TECHNE Corp
- Ticker
- TECH (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Minneapolis, MN
- Incorporated in
- MN
- Fiscal year end
- June 30
- SEC CIK
- 842023
- Former names
- TECHNE CORP /MN/
Frequently asked questions
What exchange is BIO-TECHNE Corp listed on?
BIO-TECHNE Corp trades on the Nasdaq under the ticker symbol TECH.
What industry is BIO-TECHNE Corp in?
BIO-TECHNE Corp is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is BIO-TECHNE Corp headquartered?
BIO-TECHNE Corp's business address on file with the SEC is in Minneapolis, MN.
When does BIO-TECHNE Corp's fiscal year end?
BIO-TECHNE Corp's fiscal year ends on June 30.
How much revenue did BIO-TECHNE Corp report?
BIO-TECHNE Corp reported $1.22B in revenue for calendar year 2026, according to its SEC filings.